Search
for
Sort by
Research 61–90 of 508
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Neurosteroids Are Endogenous Neuroprotectants in an Ex Vivo Glaucoma Model
- The Effect of 5 -Reductase Inhibitors on Erectile Function
- Post-finasteride syndrome: a surmountable challenge for clinicians
- Gas chromatography/mass spectrometry based hair steroid profiling may reveal pathogenesis in hair follicles of the scalp
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- 5α-Reductase inhibitors in androgenetic alopecia
- Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α-reductase
- The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson’s disease
- Dutasteride nanocapsules for hair follicle targeting: Effect of chitosan-coating and physical stimulus
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
- Frontal fibrosing alopecia: Regrowth following cessation of sunscreen on the forehead
- Pharmacogenetic analysis of human steroid 5α reductase type II: comparison of finasteride and dutasteride
- Rapid and Sensitive LC–MS–MS Method for the Simultaneous Estimation of Alfuzosin and Dutasteride in Human Plasma
- Hormonal therapies for hidradenitis suppurativa: Review
- Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia
- Dutasteride for the treatment of benign prostatic hyperplasia
- Frontal Fibrosing Alopecia: A Review
- A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
- Oral Testosterone in Oil: Pharmacokinetic Effects of 5 Reduction by Finasteride or Dutasteride and Food Intake in Men
- 5‐alpha‐reductase inhibitor treatment for frontal fibrosing alopecia: an evidence‐based treatment update
- Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review
- Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
- Testosterone Metabolism in Human Skin Cells in vitro and Its Interaction with Estradiol and Dutasteride
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
- Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors
- Comparison of clinical trials with finasteride and dutasteride.